Accelerating patient recruitment in a specialised anti-infective therapy area

The Challenge

At Month 5 of a critical anti-infective clinical trial — under the management of another CRO — only 16 patients had been recruited, far below the target of 43. The study, run across 17 U.S. sites, was struggling. Recruitment had stalled, and the existing CRO couldn’t overcome site-level and therapy-specific hurdles. Micron was brought in to turn it around.

Micron's Contribution

Our Approach & Impact

When Micron took over, recruitment was stuck at under 5 patients/month, well short of the 8/month target. Within just one month, we hit the target. In the months that followed, we didn’t just meet expectations — we consistently exceeded them. By the final month, patient recruitment reached an impressive 140, closing the study on time. What made the difference? Our in-depth therapy area knowledge and renewed site engagement. By understanding each site’s strengths and blockers, our team helped remove recruitment barriers fast.